U.S. markets close in 2 hours 42 minutes

Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne

Zacks Equity Research

For Immediate Release

Chicago, IL – May 29, 2020 – Stocks in this week’s article are Minerva Neurosciences Inc. NERV, Liquidia Technologies Inc. LQDA, Calix Inc. CALX, Avenue Therapeutics Inc. ATXI and The ExOne Co. XONE.

5 Stocks with Recent Price Strength to Tap Wall Street Rally

Wall Street's new bull market that started in mid-April, ending the coronavirus-induced short bear market, has gathered pace from last week. After a fabulous April, Wall Street is on track to close th is month in positive territory, defying the well-known financial-world adage "Sell in May and go away."

Month to date, these three indexes are up 4.9%, 4.3% and 5.9%, respectively. Besides these three large-cap centric indexes, the small-cap specific Russell 2000 Index is performing strongly in May with a gain of 9.6% so far.

Gradual reopening of the U.S. and global economy, recently released better-than-expected economic data, positive developments on vaccines for COVID-19 and an unprecedented stimulus package injected by the United States and other major economies are fueling the new bull market.

At this stage, wouldn’t it be a safer strategy to look for stocks that are winners and have the potential to gain further?

Sounds Good? Here’s How to Execute It:

One should primarily target stocks that have recently been on a bull run. Actually, stocks seeing price strength recently have a high chance of carrying the momentum forward.

If a stock is continuously witnessing an uptrend, there must be a solid reason or else it would have probably crashed. So, looking at stocks that are capable of beating the benchmark that they have set for themselves seems rational.

However, recent price strength alone cannot create magic. Therefore, you need to set other relevant parameters to create a successful investment strategy.

Here’s how you should create the screen to shortlist the current as well as the potential winners.

For the rest of this Screen of the Week article please visit Zacks.com at:https://www.zacks.com/stock/news/949029/5-stocks-with-recent-price-strength-to-tap-wall-street-rally

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: www.Zacks.com

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

 

 

 

                                                                                     


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Calix, Inc (CALX) : Free Stock Analysis Report
 
Minerva Neurosciences, Inc (NERV) : Free Stock Analysis Report
 
The ExOne Company (XONE) : Free Stock Analysis Report
 
Avenue Therapeutics, Inc. (ATXI) : Free Stock Analysis Report
 
Liquidia Technologies, Inc. (LQDA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research